SCHEMBL3397251

SCHEMBL3397251

CC(=O)N1c2ccc(NC(=O)OCC3c4ccccc4-c4ccccc43)cc2C(C)=CC1(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.52
LMNA P02545 1/20 0.51
ALDH1A1 P00352 9/20 0.45
KDM4E B2RXH2 8/20 0.45
MAPT P10636 8/20 0.45
ALOX12 P18054 5/20 0.45
HPGD P15428 4/20 0.45
GAA P10253 4/20 0.45
THRB P10828 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
HTT P42858 4/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MAPK1 P28482 2/20 0.45
KMT2A Q03164 4/20 0.43
NPSR1 Q6W5P4 4/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MEN1 O00255 2/20 0.41
POLB P06746 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2193659 0.85 LMNA (0.47) EPHX2LMNAALDH1A1KDM4EMAPT
SCHEMBL2189826 0.78 FSHR (0.64) KMT2ANPSR1MEN1TSHRFSHR
SCHEMBL1323212 0.77 LMNA (0.51) LMNAALDH1A1KDM4EMAPTALOX12
SCHEMBL3396086 0.76 FSHR (0.60) EPHX2KMT2ANPSR1MEN1TSHR
SCHEMBL3394449 0.74 FSHR (0.54) MAPTFSHR
SCHEMBL2194358 0.74 TSHR (0.62) EPHX2KMT2ATSHRFSHR
SCHEMBL14647849 0.73 EPHX2 (0.64) EPHX2ALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL8366871 0.73 EPHX2 (0.64) EPHX2LMNAALDH1A1HPGDKMT2A
SCHEMBL16977027 0.73 EPHX2 (0.75) EPHX2LMNAALDH1A1MAPTHTT
SCHEMBL12071180 0.72 EPHX2 (0.67) EPHX2TDP1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674909-B2 Biphenyl-4-carboxylic acid {1-acetyl-4-[4-(2-dimethylammo-ethoxy-phenyl]-2,2,4-trimethyl-1,2,3,4-tetrahydro-quinolin-6-yl}-amide; fertility regulation; follicle stimulating hormone (FSH) N.V. ORGANON (NL) 2010-03-09 US disclosed
EP-1578727-B1 TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS FSH RECEPTOR MODULATORS ORGANON NV (NL) 2008-04-16 EP disclosed
US-20060167047-A1 Tetrahydorquinoline derivatives and their use as fsh receptor modulators MERCK SHARP & DOHME B.V. (NL) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167047-A1 Tetrahydorquinoline derivatives and their use as fsh receptor modulators FSHR, GNRHR, LHCGR EPHX2 3587/4885LMNA 4010/4885ALDH1A1 2019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.